Member Info for doze

Thanks for that news, got an email from XEN at 3 pm http://ir.xeneticbio.com/secfiling.cfm?filingid=1662252-16-171&CIK=1534525

results tomorrow are anticipated without expectation so will be interesting to see how things are going. http://www.matthey.com/investor/financialcalendar 2nd June Announcement of results for the year ending 31st March 2016

to go up again after retreating through one year's gains. It is tricky rising against a falling Chinese market and has had to go with the trend.

This company does not have the same development costs as a drug developer, the regulatory hurdles are less due to the dCELL scaffold being a medical device rather than a medicine and they should not need to 'come back to the market' as hopefully the sales of their devices will take off. London South East has it as 'financial sector' rather than their Medicine and Biotech Research Sector London Stock Exchange is as you say.

Tissue Regenix is a leading medical devices company in the field of regenerative medicine.

That chart looks like a bull flag about to break out to me!

very welcome in todays environment. I bought a small stake at £18/share so well pleased. Second time I've been invested, last time at £10.44 on 22/3/12 for a mere 10% profit 7 months later. Up 44% this time. Should break the £1bn mark soon. Building a tremendous hospital business set to attract health tourism.

Executive Chairman gives TB the freedom to be a roving salesman which I think he has to do a lot of so would need a CEO who can keep an eye on the nuts and bolts in head office.

"A lot of companies have had problems with corporate governance, and it's unclear why the exchange doesn't do anything about it," said Colin McLean, Chief Executive of SVM Asset Management and an investor in the market. He is an investor in Hutchison China Medtech, one of the few Chinese AIM stocks to have risen in price since its launch. Its shares are up nearly five-fold since listing. (Reporting by Alasdair Pal and Patrick Graham; Editing by Hugh Lawson http://www.lse.co.uk/ShareNews.asp?shareprice=HCM&code=davuzce5&headline=UK_advisers_struggling_with_Chinese_stock_listings__survey

I think so too; had been expecting ARM to rise after recent results, they keep their eye on the ball and don't need to bother about anything going on in the demand economy because so many different products are ussing and going to use their software and now ARM have covered themselves on the robotics front- smart movers.

now have 15% of company as reward lined up and if they are there just to get shareholders hyped up at the prospect of tripling the SP then it is the sort of management of expectation that is out of favour. This is a company whose product is needed and sells itself without management pretending they deserve a global magnate size remuneration. The company just needs steady organic growth not a tripling of prospects in two years.

http://www.londonstockexchange.com/exchange/news/market-news/market-news-detail/PIM/12821701.html Doesn't he get a wage. This is the sort of remuneration that has gone out of fashion nowadays, a real shot in the foot for PIM.

I liked them too after the pp win and held through Feb but sold at lack of movement. I think the retail outlook is uncertain and London property topping out could be negative and of course stocks are being hit by the Chancellor and Governor of the BoE, both donig a great job for Britain. With debt to service there are a lot of uncertainties but eventually should succeed.

was poorly advised if this support continues. More good news in the pipeline needed. the wife of Mr Leonard Sim, a former Director of the Company, sold a total of 433,940 ordinary shares of 1 penny each in the Company ("Ordinary Shares") during the period from 15 March 2016 to 1 April 2016 through her private client broker, http://www.londonstockexchange.com/exchange/news/market-news/market-news-detail/ACSO/12813583.html

I noticed those figures, the move to US and reincorporation fees has certainly been pricey but these manoeuverings are what Scott is trained at so hope he has everything tied up. I just wonder where the Lipoxen investors come into it!

All that lot hadn't sunk in with me but quite a target to aim for. good rise today.

http://ir.xeneticbio.com/secfiling.cfm?filingid=1019687-16-6175&CIK=1534525

to conquer the world has started!

Percent of Beneficial Ownership of Common Stock http://ir.xeneticbio.com/secfiling.cfm?filingid=1019687-16-6040&CIK=1534525 we don't seem to be included on this list, are we disenfranchised? and totals up to 103.1%

That says 2.408m. Lets hope they are right to build up their holding. ACSO do align themselves with their clients and are not rip off merchants. I hope they get a good few contracts in Asia and the Middle East to continue their growth.